Jimin Min

Jimin Min

Auto-generated profile, based on publicly available information

Jimin Min

Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJimin Min
Jimin Min
PVPaige N. Vega
Paige N. Vega
AEAmy C. Engevik
Amy C. Engevik
JWJanice A. Williams
Janice A. Williams
QYQing Yang
Qing Yang
ECEunyoung Choi
Eunyoung Choi
Dysplasia is considered a key transition state between pre-cancer and cancer in gastric carcinogenesis. However, the cellular or phenotypic heterogeneity and mechanisms of dysplasia progression have not been elucidated. We have established metaplastic and dysplastic organoid lines, derived from Mist1-Kras(G12D) mouse stomach corpus and studied distinct cellular behaviors and characteristics of metaplastic and dysplastic organoids. We also examined functional roles for Kras activation in dysplasia progression using Selumetinib, a MEK inhibitor, which is a downstream mediator of Kras signaling. Here, we report that dysplastic organoids die or show altered cellular behaviors and diminished aggressive behavior in response to MEK inhibition. However, the organoids surviving after MEK inhibition maintain cellular heterogeneity. Two dysplastic stem cell (DSC) populations are also identified in dysplastic cells, which exhibited different clonogenic potentials. Therefore, Kras activation controls cellular dynamics and progression to dysplasia, and DSCs might contribute to cellular heterogeneity in dysplastic cell lineages.